OVIT (OncoVista Innovative Therapies) Total Liabilities: $6.65 Mil (As of Sep. 2015)


What is OncoVista Innovative Therapies Total Liabilities?

OncoVista Innovative Therapies OVIT Total Liabilities is $6.65 Mil as of Sep. 2015.

OncoVista Innovative Therapies's Total Liabilities for the quarter that ended in Sep. 2015 was $6.65 Mil.

OncoVista Innovative Therapies's quarterly Total Liabilities increased from Mar. 2015 ($6.00 Mil) to Jun. 2015 ($7.07 Mil) but then declined from Jun. 2015 ($7.07 Mil) to Sep. 2015 ($6.65 Mil).

OncoVista Innovative Therapies's annual Total Liabilities increased from Dec. 2012 ($2.25 Mil) to Dec. 2013 ($3.22 Mil) and increased from Dec. 2013 ($3.22 Mil) to Dec. 2014 ($5.68 Mil).

OncoVista Innovative Therapies Total Liabilities Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Total Liabilities Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.89 2.31 2.25 3.22 5.68

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.21 5.68 6.00 7.07 6.65

OncoVista Innovative Therapies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

OncoVista Innovative Therapies's Total Liabilities for the fiscal year that ended in Dec. 2014 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.976+(0+0.7
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.68

Total Liabilities=Total Assets (A: Dec. 2014 )-Total Equity (A: Dec. 2014 )
=0.013--5.663
=5.68

OncoVista Innovative Therapies's Total Liabilities for the quarter that ended in Sep. 2015 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.951+(0+2.2204460492503E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=6.65

Total Liabilities=Total Assets (Q: Sep. 2015 )-Total Equity (Q: Sep. 2015 )
=0.061--6.59
=6.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $6.65 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Total Liabilities of $6.65 Mil as of Sep. 2015. The total amount of liabilities as recorded on a company's balance sheet. View historical data for OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Total Liabilities too high?
OncoVista Innovative Therapies' current Total Liabilities is $6.65 Mil.
How does OncoVista Innovative Therapies' Total Liabilities compare to RSPI and HSTC?
OncoVista Innovative Therapies' Total Liabilities of $6.65 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Total Liabilities is $6.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Total Liabilities of $6.65 Mil. The current Total Liabilities is $6.65 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Total Liabilities is $6.65 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.